Name
University of Phoenix
NSG/498 Senior Leadership Practicum
Prof. Name
Date
Methicillin-resistant Staphylococcus aureus (MRSA) can be effectively managed in healthcare settings through consistent infection prevention practices, active surveillance, appropriate use of personal protective equipment (PPE), staff education, environmental cleaning, and evidence-based clinical decision-making. A successful MRSA management plan combines continuous monitoring with strong organizational support so healthcare professionals can identify transmission risks early, follow recommended precautions, and improve patient outcomes.
Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of S. aureus that has developed resistance to methicillin and several commonly used antibiotics. MRSA can cause a range of infections, including wound infections, bloodstream infections, pneumonia, and surgical-site infections. In healthcare environments, transmission can occur through direct contact with infected or colonized individuals, contaminated hands, equipment, or environmental surfaces.
MRSA is particularly important for healthcare organizations because infections can increase treatment complexity, length of hospital stay, healthcare costs, and the risk of serious complications. Effective prevention therefore requires more than treating individual infections. Hospitals and other healthcare facilities must establish systems that reduce transmission and support healthcare workers in consistently following infection prevention practices.
A comprehensive MRSA management plan supports both patient safety and organizational quality improvement. When infection prevention strategies are consistently implemented, healthcare organizations can reduce preventable transmission and improve the reliability of clinical care.
Effective MRSA management can help organizations:
Reduce healthcare-associated infections (HAIs)
Improve patient safety and clinical outcomes
Strengthen adherence to infection prevention practices
Identify MRSA transmission trends earlier
Reduce avoidable healthcare utilization and costs
Support evidence-based nursing and medical practice
Promote a culture of safety and accountability
A successful MRSA management plan should integrate surveillance, infection prevention, staff education, environmental controls, and appropriate clinical management. Two important organizational priorities are continuous monitoring and adequate support for healthcare professionals.
Healthcare organizations should maintain systems for monitoring MRSA infections and evaluating infection prevention performance. Surveillance data can help infection prevention teams identify changes in infection rates, recognize potential outbreaks, and determine whether interventions are producing measurable improvements.
A surveillance program may track:
MRSA infection rates and trends
Healthcare-associated MRSA cases
Compliance with hand hygiene and transmission-based precautions
Appropriate use of PPE
Patient outcomes
Infection prevention audit results
Potential transmission clusters
Surveillance should not be viewed simply as data collection. The information should be reviewed regularly and used to guide quality improvement decisions. When an increase in MRSA infections is identified, healthcare leaders can investigate possible causes and implement targeted corrective measures.
Standard precautions should be applied to all patient care, while additional transmission-based precautions should be used when clinically indicated. For patients with MRSA, healthcare organizations should follow current infection prevention guidance regarding contact precautions, patient placement, PPE, hand hygiene, and environmental cleaning.
Healthcare workers should receive practical education on when and how to use PPE, how to perform hand hygiene correctly, and how to prevent contamination of equipment and surfaces.
Hand hygiene remains one of the most important measures for preventing the spread of healthcare-associated pathogens. Healthcare organizations should make alcohol-based hand sanitizer and handwashing facilities readily accessible and regularly monitor adherence.
Education alone may not be sufficient. Leadership support, convenient access to supplies, performance feedback, and routine auditing can help improve long-term compliance.
Healthcare professionals need appropriate equipment, education, and organizational support to implement infection prevention practices consistently.
Important resources include:
Appropriate PPE
Hand hygiene supplies
Environmental cleaning products
Infection prevention education
Access to current clinical guidelines
Reliable surveillance and reporting systems
Staff training and competency assessment
When staff members have the necessary resources and understand why infection prevention practices matter, organizations are better positioned to sustain improvements.
MRSA interventions should be evaluated using objective and clinically meaningful performance indicators. A reduction in MRSA infections is an important outcome, but it should be considered alongside process measures that show whether prevention strategies are actually being implemented.
Potential indicators include:
MRSA healthcare-associated infection rates
Compliance with hand hygiene
Compliance with appropriate PPE use
Adherence to transmission-based precautions
Completion of infection prevention education
Timeliness and completeness of surveillance reporting
Environmental cleaning compliance
Staff participation in quality improvement activities
Patient safety and clinical outcome measures
Using both outcome and process measures provides a more complete picture of project effectiveness.
A well-designed MRSA management program should produce benefits for healthcare leaders, healthcare professionals, patients, and the organization as a whole.
Healthcare leaders should be able to establish reliable surveillance systems, allocate appropriate resources, and reinforce organizational accountability for infection prevention.
Leadership involvement is particularly important because infection prevention requires coordination across multiple departments rather than responsibility being placed solely on infection prevention personnel.
Healthcare professionals should demonstrate improved adherence to evidence-based infection prevention practices. Education, feedback, and access to appropriate resources can help nurses, physicians, technicians, and other staff members incorporate MRSA prevention into routine patient care.
Patients should benefit from:
Lower risk of healthcare-associated MRSA transmission
Safer care environments
Earlier identification of infection risks
Improved adherence to appropriate treatment and precautions
Better overall quality of care
Implementation should be organized into clearly defined stages so that responsibilities, resources, and evaluation measures are established before the intervention begins.
The project team should meet with hospital administrators and key decision-makers to explain the clinical importance of MRSA prevention and present the proposed management plan.
Leadership discussions should address surveillance requirements, staff education, PPE availability, environmental cleaning, reporting procedures, and resource allocation.
Successful implementation requires collaboration among nurses, physicians, infection prevention specialists, laboratory personnel, environmental services, quality improvement staff, and administrators.
The team should establish consistent expectations for MRSA prevention and ensure that staff understand the organization’s protocols.
Education should focus on practical infection prevention behaviors rather than relying exclusively on written policies.
Training may address:
Hand hygiene
PPE selection and use
Contact and transmission-based precautions
Patient and equipment handling
Environmental cleaning
MRSA surveillance and reporting
Appropriate antibiotic use
Recognition of potential transmission risks
Competency assessments and periodic refresher education can reinforce these practices.
Once the surveillance system is established, the organization should collect relevant infection data and review results at predetermined intervals.
Trend analysis can help determine whether MRSA infections are increasing, decreasing, or remaining stable. Unexpected increases should trigger an appropriate investigation and corrective action.
The final implementation stage involves comparing baseline data with post-intervention results. Findings should be shared with relevant stakeholders and used to identify additional improvement opportunities.
Quality improvement should be treated as an ongoing process rather than a one-time project.
The resources required will depend on the size of the healthcare organization and the scope of the intervention. A proposed project budget may be used to support coordination, education, communication, data collection, and staff engagement.
| Team Member | Responsibility | Proposed Budget |
|---|---|---|
| Team Leader | Coordinates the project and communicates with leadership | $3,000 |
| Assistant Leader | Supports implementation activities | $200 |
| Treasurer | Manages project finances and budget tracking | $300 |
| Three Team Members | Collaborate with the MRSA/infection prevention team and clinical staff | $1,000 |
| Total | $4,500 |
This budget should be considered a project-planning estimate rather than a universal cost of implementing an MRSA program. Actual expenses will vary according to organizational size, staffing structure, existing infection prevention infrastructure, and available resources.
Implementation may require:
Computers or laptops
Secure internet access
Hospital-approved communication systems
Infection surveillance software or reporting tools
Appropriate PPE
Hand hygiene supplies
Environmental cleaning supplies
Educational materials
Technology should support secure communication and data management while complying with organizational privacy and security requirements.
A two-month implementation period can provide a practical structure for an initial quality improvement project. Weekly progress reviews should be used to identify barriers and make timely adjustments.
Establish collaboration among project members, hospital leadership, infection prevention specialists, and clinical departments.
Implement or strengthen MRSA monitoring processes and confirm that staff have access to necessary clinical resources and infection prevention supplies.
Assess staff participation, infection prevention compliance, and implementation challenges. Provide feedback and additional education when needed.
Review MRSA infection data, process measures, patient safety indicators, and staff compliance to determine whether the intervention achieved its objectives.
Continuous monitoring is essential for determining whether an MRSA management plan is functioning as intended. Data should be collected consistently and reviewed according to a predefined schedule.
Monitoring activities may include:
Daily project activity documentation
Weekly implementation reviews
Infection prevention audits
MRSA surveillance reports
Hand hygiene observations
PPE compliance assessments
Staff education records
Patient outcome measurements
Regular feedback allows healthcare leaders to identify implementation problems before they become persistent barriers.
MRSA prevention projects may face operational, financial, and organizational challenges. Anticipating these barriers allows the project team to develop mitigation strategies before implementation problems affect outcomes.
Insufficient funding may restrict access to PPE, technology, education, or surveillance resources. Leaders should prioritize interventions based on infection risk, clinical evidence, and available resources.
Staff may be less likely to adopt new practices when they perceive interventions as time-consuming or disconnected from clinical priorities. Involving frontline healthcare workers in planning and providing meaningful feedback can improve engagement.
MRSA prevention requires cooperation across multiple departments. Regular interdisciplinary meetings and clearly assigned responsibilities can improve communication and accountability.
Inconsistent communication may result in misunderstandings about precautions or reporting requirements. Standardized protocols, accessible educational materials, and reliable communication channels can reduce this risk.
The Iowa Model Revised provides a structured approach for translating evidence into clinical practice. It can be used to guide the development, implementation, and evaluation of an MRSA management intervention.
The model encourages healthcare teams to identify practice problems, develop focused clinical questions, evaluate available evidence, implement appropriate changes, and assess outcomes.
The model can guide the MRSA project through the following process:
Identify MRSA transmission or infection prevention as a clinical priority.
Develop a focused PICOT question.
Review current research and clinical guidelines.
Evaluate the strength and relevance of available evidence.
Select appropriate evidence-based interventions.
Implement the intervention with stakeholder support.
Evaluate patient and organizational outcomes.
Sustain effective changes through continued monitoring.
This approach helps ensure that MRSA management decisions are based on current evidence rather than relying solely on routine practice or individual preference.
Evaluation should occur throughout the project rather than only at the end. Both short-term implementation outcomes and longer-term clinical outcomes should be considered.
Short-term evaluation may focus on whether the intervention has been successfully implemented. Examples include functional surveillance systems, adequate supplies, completed staff education, and improved compliance with infection prevention protocols.
Long-term evaluation should examine whether the intervention produces sustained improvements, such as:
Reduced healthcare-associated MRSA infections
Improved patient safety
Better adherence to infection prevention standards
Sustained staff competency
Stronger organizational infection prevention practices
Formative evaluation examines implementation progress while the project is underway. It can identify problems with staff participation, resource availability, education, surveillance systems, or communication.
Summative evaluation examines the overall effectiveness of the intervention after implementation. Measures may include changes in MRSA infection rates, infection prevention compliance, patient outcomes, and organizational quality indicators.
The organization should compare post-intervention results with baseline data whenever possible. This approach provides a clearer assessment of whether observed changes are associated with the intervention.
Effective MRSA management requires an integrated approach that combines surveillance, infection prevention, staff education, environmental controls, appropriate precautions, and organizational leadership.
The most important principles are:
Continuous surveillance helps healthcare organizations identify MRSA trends and respond to potential transmission risks.
Hand hygiene and appropriate transmission-based precautions remain fundamental components of infection prevention.
Healthcare workers need adequate PPE, education, clinical guidance, and leadership support.
Process measures and clinical outcomes should both be monitored to evaluate program effectiveness.
Interdisciplinary collaboration improves consistency across clinical departments.
Evidence-based practice models, such as the Iowa Model Revised, can provide a structured framework for implementing and evaluating practice changes.
MRSA prevention should be treated as an ongoing quality improvement priority rather than a short-term project.
MRSA stands for methicillin-resistant Staphylococcus aureus. It is a strain of S. aureus that is resistant to methicillin and several related antibiotics. MRSA can cause skin and soft-tissue infections as well as serious infections such as bloodstream infections and pneumonia.
Hospitals can reduce MRSA transmission by strengthening hand hygiene, using appropriate PPE and transmission-based precautions, improving environmental cleaning, educating healthcare workers, monitoring infection trends, and implementing evidence-based infection prevention practices.
MRSA surveillance helps healthcare organizations identify infection trends, detect potential transmission problems, evaluate prevention strategies, and determine whether additional interventions are needed.
Hand hygiene helps prevent healthcare workers from transferring MRSA between patients, equipment, and environmental surfaces. Consistent hand hygiene is therefore a fundamental component of healthcare-associated infection prevention.
Isolation and transmission-based precautions should be determined according to current infection prevention guidance, the patient’s clinical condition, the healthcare setting, and organizational policy. Healthcare facilities should follow current CDC and applicable public health recommendations rather than applying a single approach to every situation.
Success can be evaluated through a combination of outcome and process measures. These may include MRSA healthcare-associated infection rates, hand hygiene compliance, appropriate PPE use, adherence to precautions, staff education completion, environmental cleaning compliance, and patient safety outcomes.
The Iowa Model Revised is an evidence-based practice framework that helps healthcare professionals identify clinical problems, evaluate evidence, implement practice changes, and measure outcomes. It can provide a structured approach for developing and evaluating MRSA prevention initiatives.
Leadership provides the resources, policies, staffing support, education, accountability, and organizational culture needed to sustain infection prevention practices. Without leadership support, individual healthcare workers may have difficulty maintaining consistent infection prevention practices.
Centers for Disease Control and Prevention. (2024). Methicillin-resistant Staphylococcus aureus (MRSA). https://www.cdc.gov/mrsa/
Centers for Disease Control and Prevention. (2024). Core infection prevention and control practices for safe healthcare delivery in all settings. https://www.cdc.gov/infection-control/hcp/core-practices/
Centers for Disease Control and Prevention. (2024). Hand hygiene in healthcare settings. https://www.cdc.gov/clean-hands/hcp/
Hanrahan, K., Fowler, C., & McCarthy, A. M. (2019). Iowa Model Revised: Research and evidence-based practice application. Journal of Pediatric Nursing, 48, 121–122. https://doi.org/10.1016/j.pedn.2019.04.023
World Health Organization. (2022). Global report on infection prevention and control. World Health Organization. https://www.who.int/publications/i/item/9789240051164
World Health Organization. (2024). Infection prevention and control. https://www.who.int/teams/integrated-health-services/infection-prevention-control
SHEA/IDSA/APIC. (2022). Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 update. Infection Control & Hospital Epidemiology, 44(7), 1033–1046. https://doi.org/10.1017/ice.2022.98
